LFVN, US53222K2050

LifeVantage may report November 3: what it means for LifeVantage stock

Published on 10/17/2026 at 19:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2026 revenue was USD 182.59 million versus a USD 224.19 million threshold. LifeVantage stock last traded at USD 6.00 on October 16, 2026.

Reporting dates and annual figures

MarketBeat lists November 3, 2026 as the estimated first-quarter earnings date.
Fiscal 2026 revenue totaled USD 182.59 million against a USD 224.19 million threshold.
LifeVantage stock last traded at USD 6.00 on October 16, 2026 at 4:00 p.m. ET on Nasdaq.
The annual meeting is scheduled for November 5, 2026.

LFVN, US53222K2050, Illustration mit AI erstellt.

LifeVantage Corporation (ISIN US53222K2050) may report first-quarter fiscal 2027 results on November 3, 2026, after the market closes. MarketBeat lists the date as an estimate and the conference call for 4:30 p.m. ET. The last Nasdaq quote was USD 6.00 on October 16, 2026 at 4:00 p.m. ET.

What November 3 means for investors

The next report will be the first scheduled quarterly update under LifeVantage's calendar-year reporting structure. MarketBeat expects revenue of USD 40.49 million and earnings per share of USD 0.03 for the first quarter of fiscal 2027. The same source lists prior-year revenue of USD 47.56 million and prior-year earnings per share of USD 0.18, setting a clear comparison for the November release.

Fiscal 2026 revenue sets the baseline

LifeVantage reported fiscal 2026 revenue of USD 182.59 million and net income attributable to common shareholders of USD 5.07 million. Operating cash flow for the fiscal year was USD 10.24 million. In the company proxy statement, Boardroom Alpha reported a fiscal 2026 revenue threshold of USD 224.19 million for performance awards, while actual revenue was USD 182.59 million.

Price range remains wide

The stock's 52-week Nasdaq range is USD 3.90 to USD 11.71, with the October 16 quote sitting below the midpoint of USD 7.81. The market capitalization was USD 75.5 million on October 16, 2026, and the quote showed a trailing P/E ratio of 15.00. LifeVantage develops dietary supplements, skincare products and wellness solutions through direct sales and digital commerce, according to its investor-relations overview.

Valuation and upcoming dates

The annual meeting is scheduled for November 5, 2026, according to the company's proxy materials. The November 3 earnings date comes first and is the next scheduled corporate event. LifeVantage's fiscal year ended June 30, 2026, so the coming report will cover the opening quarter of fiscal 2027.

Comparison with peers

LFVN (Nasdaq, USD): 0.00 percent, P/E 15.00, market capitalization USD 75.5 million
Edgewell Personal Care (NYSE, USD): minus 0.68 percent, P/E minus 13.89, market capitalization USD 1.3 billion
e.l.f. Beauty (NYSE, USD): minus 2.21 percent, P/E 113.51, market capitalization USD 6.7 billion

Dates frame the stock report

LifeVantage enters the next reporting cycle with fiscal 2026 revenue of USD 182.59 million and a market value of USD 75.5 million. The November 3 estimate and the November 5 annual meeting give investors two dated events for the calendar.

The last Nasdaq quote was USD 6.00 on October 16, 2026 at 4:00 p.m. ET.